{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:34Z","timestamp":1787032774013,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,10]]},"DOI":"10.7759\/cureus.110585","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:19:43Z","timestamp":1781086783000},"source":"Crossref","is-referenced-by-count":1,"title":["Relapsed Type II Lepromatous Reaction With Drug-Induced Hemolysis: A Case Report Highlighting Therapeutic Challenges"],"prefix":"10.7759","author":[{"given":"Mohamed A","family":"Baghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyat Salah Gaffar","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiada","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suha","family":"Babikir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.080","article-title":"Leprosy: clinical aspects and diagnostic techniques","volume":"83","author":"Maymone MB","year":"2020","unstructured":"Maymone MB, Laughter M, Venkatesh S, et al.. Leprosy: clinical aspects and diagnostic techniques. J Am Acad Dermatol. 2020, 83:1-14. 10.1016\/j.jaad.2019.12.080","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1298749","article-title":"Leprosy: treatment, prevention, immune response and gene function","volume":"15","author":"Li X","year":"2024","unstructured":"Li X, Ma Y, Li G, et al.. Leprosy: treatment, prevention, immune response and gene function. Front Immunol. 2024, 15:1298749. 10.3389\/fimmu.2024.1298749","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3201\/eid2908.220367","article-title":"Case report of leprosy in Central Florida, USA, 2022","volume":"29","author":"Bhukhan A","year":"2023","unstructured":"Bhukhan A, Dunn C, Nathoo R. Case report of leprosy in Central Florida, USA, 2022. Emerg Infect Dis. 2023, 29:1698-700. 10.3201\/eid2908.220367","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"10","author":"Britton WJ","year":"2004","unstructured":"Britton WJ, Lockwood DN. Leprosy. Lancet. 2004, 10:1209-19. 10.1016\/S0140-6736(04)15952-7","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44767","article-title":"Leprosy classification, clinical features, epidemiology, and host immunological responses: failure of eradication in 2023","volume":"15","author":"Alrehaili J","year":"2023","unstructured":"Alrehaili J. Leprosy classification, clinical features, epidemiology, and host immunological responses: failure of eradication in 2023. Cureus. 2023, 15:e44767. 10.7759\/cureus.44767","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2022.2149943","article-title":"Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria","volume":"27","author":"Hu Y","year":"2022","unstructured":"Hu Y, Geere M, Awan M, et al.. Dapsone-induced methemoglobinemia and hemolysis in a woman without G6PD deficiency presenting with idiopathic urticaria. Hematology. 2022, 27:1253-8. 10.1080\/16078454.2022.2149943","journal-title":"Hematology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-0816-y","article-title":"Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature","volume":"4","author":"Lee SM","year":"2015","unstructured":"Lee SM, Geetha D. Dapsone induced hemolysis in a patient with ANCA associated glomerulonephritis and normal G6PD level and implications for clinical practice: case report and review of the literature. Springerplus. 2015, 4:29. 10.1186\/s40064-015-0816-y","journal-title":"Springerplus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.9697","article-title":"Borderline lepromatous leprosy with type 1 reaction: a challenging diagnostic case","volume":"12","author":"Saray PL","year":"2024","unstructured":"Saray PL, Dalit ZF, Itzel FB, Montserrat RE, Elisa VM, Roberto AG. Borderline lepromatous leprosy with type 1 reaction: a challenging diagnostic case. Clin Case Rep. 2024, 12:e9697. 10.1002\/ccr3.9697","journal-title":"Clin Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49155","article-title":"Immunopathogenesis of type 1 and type 2 leprosy reaction: an update review","volume":"15","author":"Dewi DA","year":"2023","unstructured":"Dewi DA, Djatmiko CB, Rachmawati I, Arkania N, Wiliantari NM, Nadhira F. Immunopathogenesis of type 1 and type 2 leprosy reaction: an update review. Cureus. 2023, 15:e49155. 10.7759\/cureus.49155","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03485.x","article-title":"Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions","volume":"150","author":"Iyer A","year":"2007","unstructured":"Iyer A, Hatta M, Usman R, et al.. Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions. Clin Exp Immunol. 2007, 150:210-6. 10.1111\/j.1365-2249.2007.03485.x","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495473-relapsed-type-ii-lepromatous-reaction-with-drug-induced-hemolysis-a-case-report-highlighting-therapeutic-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:19:46Z","timestamp":1781086786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495473-relapsed-type-ii-lepromatous-reaction-with-drug-induced-hemolysis-a-case-report-highlighting-therapeutic-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.110585","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]}}}